EVALUATION OF THE INVITRO BACTERICIDAL ACTION OF CIPROFLOXACIN ON CELLS OF ESCHERICHIA-COLI IN THE LOGARITHMIC AND STATIONARY PHASES OF GROWTH

[1] ANTIBACTERIAL ACTIVITIES OF CIPROFLOXACIN, NORFLOXACIN, OXOLINIC ACID, CINOXACIN, AND NALIDIXIC-ACID [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) : 633 - 637

[2] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) : 111 - 115

[3] CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) : 319 - 326

[4] INVESTIGATIONS INTO THE MECHANISM OF ACTION OF THE ANTIBACTERIAL AGENT NORFLOXACIN [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 : 9 - 23

[5] INVITRO ACTIVITY OF CIPROFLOXACIN (BAY O 9867) [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) : 568 - 574

[6] ESCHERICHIA COLI K-12 MUTANTS RESISTANT TO NALIDIXIC ACID - GENETIC MAPPING AND DOMINANCE STUDIES [J]. JOURNAL OF BACTERIOLOGY, 1969, 99 (01) : 238 - &

[7] INVITRO STUDIES WITH CIPROFLOXACIN, A NEW 4-QUINOLONE COMPOUND [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (04) : 333 - 346

[8] Smith J. R., 1984, Proceedings of the 1984 International Conference on Parallel Processing (Cat. No. 84CH2045-3), P299

[9] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) : 559 - 564

[10] THE INVITRO AND INVIVO ACTIVITY OF CIPROFLOXACIN [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (04) : 339 - 343

[1] ANTIBACTERIAL ACTIVITIES OF CIPROFLOXACIN, NORFLOXACIN, OXOLINIC ACID, CINOXACIN, AND NALIDIXIC-ACID [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) : 633 - 637

[2] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) : 111 - 115

[3] CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) : 319 - 326

[4] INVESTIGATIONS INTO THE MECHANISM OF ACTION OF THE ANTIBACTERIAL AGENT NORFLOXACIN [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 : 9 - 23

[5] INVITRO ACTIVITY OF CIPROFLOXACIN (BAY O 9867) [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) : 568 - 574

[6] ESCHERICHIA COLI K-12 MUTANTS RESISTANT TO NALIDIXIC ACID - GENETIC MAPPING AND DOMINANCE STUDIES [J]. JOURNAL OF BACTERIOLOGY, 1969, 99 (01) : 238 - &

[7] INVITRO STUDIES WITH CIPROFLOXACIN, A NEW 4-QUINOLONE COMPOUND [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (04) : 333 - 346

[8] Smith J. R., 1984, Proceedings of the 1984 International Conference on Parallel Processing (Cat. No. 84CH2045-3), P299

[9] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) : 559 - 564

[10] THE INVITRO AND INVIVO ACTIVITY OF CIPROFLOXACIN [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (04) : 339 - 343